In the contemporary dermatological landscape, "Root Repair" has transcended traditional surface-level moisturizing. It now represents a sophisticated biological intervention targeting the basal layers and the stratum corneum. As a leading China manufacturer, Jiangsu Menuka Medical Co., Ltd. defines root repair through the lens of Information Gain: providing the skin with the precise bio-identical lipids and growth factors required to autonomously regenerate its protective barrier.
From the application of Phytosphingosine to the pioneering use of PDRN (Polydeoxyribonucleotide), our technical roadmap focuses on "Cellular Intelligence"—teaching the skin how to heal from within.
Global Export Regions
10,000+Hospitals & Clinics Served
2009Established Year
Our R&D focuses on 98% pure Phytosphingosine, a natural component of the skin barrier. By mimicking the skin's "root" lipid structure, we achieve unprecedented absorption rates for sensitive skin recovery.
Utilizing DNA fragments from salmon, our PDRN serums represent the next frontier in non-surgical repair, stimulating fibroblast activity and reducing post-procedure downtime by 40%.
We leverage machine learning to analyze dermatological data from over 10,000 clinics, optimizing ingredient synergy for various ethnic skin types and localized environmental stressors.
Founded in 2009, Jiangsu Menuka Medical Co., Ltd. is a leading innovator in the field of medical skincare and dermatological solutions. As a modern enterprise integrating R&D, intelligent manufacturing, clinical application, and global distribution, Menuka Medical is dedicated to advancing the future of professional skincare through science, safety, and innovation.
With years of expertise in dermatology and post-procedure skincare, Menuka Medical continuously develops advanced formulations and functional skincare products supported by patented technologies, clinical validation, and strict quality standards.
Unlike many Western brands that outsource ingredient sourcing, our proximity to the world's largest chemical and biotech clusters in Jiangsu allows for real-time quality control of precursors like Niacinamide and PLLA.
Our facility utilizes automated filling and emulsification machines that minimize human contact, ensuring medical-grade sterility and an annual production capacity exceeding 50 million units.
Integrated with major ports (Shanghai/Ningbo), we offer a "7-day production to shipment" turnaround for OEM partners, a critical advantage in the fast-paced beauty industry.









Navigating the complex regulatory landscape of the EU (CPNP), USA (FDA), and Southeast Asia requires more than just high-quality products. Jiangsu Menuka Medical provides comprehensive Compliance Architecture:
The "Root Repair" market is projected to reach $18.5 Billion by 2027. We are currently expanding our flagship distribution networks in North America and the Middle East, offering exclusive partnership rights to established medical skincare distributors.
Standard moisturizers create an occlusive layer to prevent water loss. Our "Root Repair" products, such as those containing Phytosphingosine and PLLA, work by signaling the skin's own biological processes to synthesize ceramide and collagen, fixing the barrier at its source.
Yes, our manufacturing facility operates under strict ISO 22716 and GMPC standards, ensuring that every product from our water treatment to final packing meets international medical-grade safety requirements.
Absolutely. We specialize in providing end-to-end solutions, from formula development and bottle design to final product labeling and QC, tailored to your brand's unique market position.
We utilize advanced freeze-drying technology (as seen in our Niacinamide Freeze-Dried Powder) and specialized emulsification techniques to maintain the bio-activity of fragile molecules until the moment of application.
Jiangsu Menuka Medical Co., Ltd. is more than a manufacturer; we are a strategic partner in skin health. We welcome distributors, medical institutions, and skincare professionals across more than 15 countries to join us in shaping the future of dermatology.